Ozempic efficacy depends on the context
Available online: 3.Zucconi S., Volpato C., Adinolfi F., Gandini E., Gentile E., Loi A., Fioriti L
WADA Prohibition The World Anti-Doping Agency classification for these peptides: GLP3 likely classified under prohibited substances as a GLP-1 receptor agonist Cagrilintide status as amylin analog may fall under peptide hormone prohibitions Combined formulation would be prohibited under multiple substance categories No Therapeutic Use Exemptions (TUEs) available for either component Detection methods under development for anti-doping testing WADAs position reflects that these remain investigational agents without regulatory approval from health authorities worldwide
The additional carbohydrate, and the requirement to specifically be timed with the carnitine supplement twice daily, is unlikely to align with the caloric needs and nutrient timing that is optimal for each athlete, during each phase of training, over the period of supplementation
Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R